SciTransfer
Organization

UNIVERSITY OF PITTSBURGH

Major US research university contributing transatlantic expertise in structural biology, digital law, mathematics, and humanities through MSCA mobility programmes.

University research groupmultidisciplinaryUS
H2020 projects
8
As coordinator
0
Total EC funding
Unique partners
70
What they do

Their core work

The University of Pittsburgh is a major US research university that contributes specialized expertise to European research consortia through the Marie Skłodowska-Curie Actions mobility programme. Its H2020 involvement spans remarkably diverse fields — from structural biology of neurodegenerative diseases and cancer care quality, to geometric harmonic analysis, digital rights law, and European integration history. Pitt serves as a transatlantic knowledge bridge, hosting visiting European researchers and enabling staff exchanges across disciplines where its faculty hold distinctive expertise.

Core expertise

What they specialise in

Structural biology and neurodegenerative diseaseprimary
2 projects

InterTAU focuses on tau protein pathology using NMR and cryo-EM; TGF-BTB investigates TGF-β signaling and peptide-based inhibitors.

Digital rights, ICT law and bioethicssecondary
1 project

LAST-JD-RIoE is a joint doctorate programme covering Internet of Things law, eHealth privacy, and human rights in digital environments.

Geometric and harmonic analysis (mathematics)secondary
1 project

GHAIA applies harmonic analysis and nonlocal PDEs to visual cortex models, satellite navigation, and automated inspection.

Cancer care quality and health services researchsecondary
1 project

INEXCA trained international staff in methodology for evaluating quality of cancer care.

European integration and migration studiesemerging
1 project

NAVSCHEN examines Schengen history, EU free movement of persons, and discourse around migration and asylum.

Biomedical tissue engineeringsecondary
1 project

LAF-GRAFT investigated lipoaspirate fluid as a cellular source, indicating regenerative medicine capabilities.

Evolution & trajectory

How they've shifted over time

Early focus
Biomedical sciences and mathematics
Recent focus
Digital law, humanities, structural biology

In its earlier H2020 phase (2015–2017), Pitt's involvement centred on biomedical topics — cancer care quality, tissue engineering, social psychology — alongside pure mathematics (harmonic analysis, PDEs, geometric modelling). From 2019 onward, the profile shifted markedly toward two new directions: digital law and ethics (IoT rights, privacy-by-design, legal informatics) and humanities-driven research (European integration history, migration, discourse analysis), while deepening its structural biology work on Alzheimer's-related tau proteins. This evolution reflects a university broadening its European engagement from STEM-heavy exchanges toward social sciences and interdisciplinary digital governance.

Pitt is expanding its European research footprint into interdisciplinary areas where technology meets law, ethics, and society — making it an increasingly relevant partner for responsible innovation programmes.

Collaboration profile

How they like to work

Role: third_party_expertReach: Global22 countries collaborated

Pittsburgh participates exclusively as a third-party contributor through MSCA mobility schemes, never as coordinator or formal consortium partner. This means individual researchers or departments join European projects to host visiting fellows or participate in staff exchanges, rather than the university driving project design. With 70 unique partners across 22 countries, the connections are broad but shallow — typical of a large university where participation is decentralised across faculties rather than managed by a central EU projects office.

Pitt has collaborated with 70 distinct partners across 22 countries, an unusually wide geographic spread reflecting the global nature of MSCA mobility actions rather than deep bilateral ties with specific institutions.

Why partner with them

What sets them apart

As one of few major US universities active in H2020 MSCA programmes, Pitt offers European consortia a transatlantic dimension that most partnerships lack — access to American research infrastructure, perspectives, and talent pipelines. Its extreme disciplinary breadth (from cryo-EM structural biology to Schengen migration history) means different departments can serve very different consortium needs. For coordinators building MSCA proposals, Pitt provides a credible non-European partner with a track record of successful third-party participation.

Notable projects

Highlights from their portfolio

  • InterTAU
    Tackles Alzheimer's-related tau protein using advanced structural biology techniques (solid-state NMR, cryo-EM), connecting fundamental research to a major therapeutic target.
  • LAST-JD-RIoE
    A joint doctorate programme at the intersection of law, technology, and human rights — unusually interdisciplinary for an MSCA-ITN, covering IoT, eHealth, and algorithmic governance.
  • GHAIA
    Bridges abstract mathematics (harmonic analysis, PDEs) with practical applications in satellite navigation and automated visual inspection — a rare pure-to-applied math collaboration.
Cross-sector capabilities
healthdigitalsocietysecurity
Analysis note: All 8 projects are third-party participations through MSCA mobility schemes with no recorded EC funding, which limits insight into Pitt's institutional commitment level. The extreme topic diversity suggests decentralised faculty-level participation rather than a strategic institutional engagement with H2020. Profile reflects individual researcher mobility rather than deep organisational involvement in EU research.